Alveolar rhabdomyosarcoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Although the pathogenesis in classic ARMS cases is thought to be driven by the 5'PAX3-3'FOXO1 fusion on derivative chromosome 13, here we report a novel cryptic insertion of 3'FOXO1 resulting in a pathogenic fusion with 5'PAX3 on inverted chromosome 2q.
|
26316324 |
2015 |
Alveolar rhabdomyosarcoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma.
|
26071485 |
2015 |
Alveolar rhabdomyosarcoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The reciprocal t(2;13)(q36.1;q14.1) in human alveolar rhabdomyosarcoma (A-RMS) creates a pathognomonic PAX3-FOXO1 fusion gene.
|
25659124 |
2015 |
Alveolar rhabdomyosarcoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
All suspected or possible ARMS tested by FISH or PCR for FOXO1 rearrangement or PAX3/7-FOXO1 fusion transcripts over a 7-year period were included.
|
25912319 |
2015 |
Alveolar rhabdomyosarcoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Fluorescence in situ hybridization revealed that the tumor cells were positive for FKHR gene rearrangement, confirming the diagnosis of ARMS.
|
24427371 |
2014 |
Alveolar rhabdomyosarcoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Here, we uncovered population heterogeneity among PAX/FOXO1-positive alveolar rhabdomyosarcoma by characterizing prosurvival networks initiated by FGFR4 signaling.
|
24550147 |
2014 |
Alveolar rhabdomyosarcoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We found disagreement in only three samples: one ES/pPNET and one embryonal rhabdomyosarcoma harbor a PAX3-FOXO1 translocation (for ARMS), and one neuroepithelioma harboring a EWS-WT1 (for DSRCT).
|
24486246 |
2014 |
Alveolar rhabdomyosarcoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Classically, the alveolar subtype is characterized by a chromosomal translocation t(2;13)(q35;q14) or t(1;13)(p36;q14) fusing the PAX3 or PAX7 gene, respectively, to the FOXO1 gene, although fusion-negative cases of alveolar rhabdomyosarcoma (ARMS) occur; these share considerably more with the genomic profiles and biological behavior of embryonal rhabdomyosarcoma than with fusion-positive ARMS.
|
24614150 |
2014 |
Alveolar rhabdomyosarcoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
FKHR-PAX3 potently inhibited myogenesis in both non-transformed myoblast cells and ARMS cells.
|
23799156 |
2013 |
Alveolar rhabdomyosarcoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
This review discusses the role of PAX3-FOXO1 in ARMS tumors.
|
23432728 |
2013 |
Alveolar rhabdomyosarcoma
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
We therefore demonstrate that PAX3-FOXO1 up-regulation of Noxa represents an unanticipated aspect of ARMS tumor biology that creates a therapeutic window to allow induction of apoptosis in ARMS cells.
|
23814486 |
2013 |
Alveolar rhabdomyosarcoma
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
In this study, we hypothesized that screening a small-molecule library might identify already existing drugs that are able to modulate the transcriptional activity of PAX3/FOXO1, the fusion protein specifically found in the pediatric tumor alveolar rhabdomyosarcoma (aRMS).
|
23372815 |
2013 |
Alveolar rhabdomyosarcoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
|
23733015 |
2013 |
Alveolar rhabdomyosarcoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
|
23645752 |
2013 |
Alveolar rhabdomyosarcoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
P-cadherin is a direct PAX3-FOXO1A target involved in alveolar rhabdomyosarcoma aggressiveness.
|
22710718 |
2013 |
Alveolar rhabdomyosarcoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A chimeric fusion RNA, PAX3-FOXO1, associated with alveolar rhabdomyosarcoma, is also present in normal non-cancer cells and tissues.
|
24089019 |
2013 |
Alveolar rhabdomyosarcoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Therapeutic cytodifferentiation in alveolar rhabdomyosarcoma without genetic change of the PAX3-FKHR chimeric fusion gene: a case study.
|
23797277 |
2013 |
Alveolar rhabdomyosarcoma
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Chimeric proteins encoded in most ARMS from the fusion of PAX3 or PAX7 with FOXO1 are expressed, result in a distinct pattern of downstream protein expression, and appear to be the proximate cause of the bad outcome associated with this subtype.
|
24113309 |
2013 |
Alveolar rhabdomyosarcoma
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
PAX3/7-FKHR gene fusions expression was detected in 56% of ARMS tumor samples.
|
23079386 |
2012 |
Alveolar rhabdomyosarcoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
To identify genes whose expression is directly affected by the level of PAX3-FKHR in an ARMS cellular-context, we first developed an ARMS cell line in which PAX3-FKHR is stably down-regulated, and showed that stably downregulating PAX3-FKHR in ARMS cells significantly decreased the cells' motility.
|
22533991 |
2012 |
Alveolar rhabdomyosarcoma
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
We performed a novel differential gene expression analysis comparing normal mesenchymal stem cells with previously generated non-tumorigenic mesenchymal stem cells expressing the PAX7-FKHR fusion gene, as well as with a known tumorigenic, PAX7-FKHR-expressing ARMS cell line, CW9019.
|
22374423 |
2012 |
Alveolar rhabdomyosarcoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
PAX3-FOXO1 and FGFR4 in alveolar rhabdomyosarcoma.
|
21882254 |
2012 |
Alveolar rhabdomyosarcoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Alveolar rhabdomyosarcoma (RMS) is an aggressive pediatric cancer of the myogenic lineage with frequent chromosomal translocations involving the PAX3 or PAX7 and FOXO1 genes.
|
22447499 |
2012 |
Alveolar rhabdomyosarcoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
To identify genes cooperating with PAX3-FOXO1 in ARMS tumorigenesis, we generated a retroviral complementary DNA (cDNA) expression library from the Rh30 ARMS cell line.
|
21177767 |
2011 |
Alveolar rhabdomyosarcoma
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Alveolar rhabdomyosarcoma (ARMS) are characterized by the expression of chimeric transcription factors Pax3-FKHR and Pax7-FKHR, due to chromosomal translocations fusing PAX3 or PAX7 with the FKHR gene.
|
21321994 |
2011 |